BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Genelex Corporation 

3000 First Ave., Suite One

Seattle  Washington  98121  U.S.A.
Phone: 206-382-9591 or 800-523-3080 Fax: 206-219-4000


SEARCH JOBS


Industry
Biotechnology

Segment
Research





 Company News
Genelex Corporation Rolls Out Lifesaving DNA Healthcare System 9/13/2012 9:56:41 AM    More...
Genelex Corporation Receives First Patent on Business Methods for Pharmacogenetics 8/1/2012 10:25:52 AM    More...
Genelex Corporation Release: Coumadin (warfarin) Patients Receive New FDA Information 8/17/2007 11:15:53 AM    More...
Genelex Corporation Release: Controversial FDA Panel Approves Drug For Use By Children; New DNA Test Alerts Physicians And Parents To Potential Harm 12/7/2006 11:58:00 AM    More...
Genelex Corporation Release: FDA Committee Supports Simple DNA Tests When Patients Are Prescribed Coumadin (Warfarin) 11/21/2006 10:14:34 AM    More...
Genelex Corporation Release: DNA Tests Now Available Determine Safe Dosage For Dangerous Drugs, Coumadin And Warfarin 10/4/2006 10:20:20 AM    More...
Strattera Safety Helped By DNA Testing, According To FDA Approved Product Labeling Notes Genelex Corporation Founder, Howard Coleman 10/19/2005 5:12:58 PM    More...
DNA-Based Personalized Medicine Training Announced By Genelex Corporation 10/19/2005 5:12:58 PM    More...
DNA Tests Now Available Reveal Possible Deadly Side Effects; Genelex Corporation Urges Users Of Vioxx, Bextra, Celebrex, Aleve And Others To Check DNA Before Taking Meds 10/19/2005 5:11:51 PM    More...
Genelex Corporation Release: Gene Tests Available To Consumers 10/19/2005 5:09:33 PM    More...

//-->